Prince HM - Search Results

1

Management of hydroxyurea resistant or intolerant polycythemia vera.

Raman I, Pasricha SR, Prince HM, Yannakou CK. Raman I, et al. Among authors: prince hm. Leuk Lymphoma. 2021 Oct;62(10):2310-2319. doi: 10.1080/10428194.2021.1901092. Epub 2021 May 5. Leuk Lymphoma. 2021. PMID: 33949918 Free article.

2

Secondary acute myeloid leukemia with inv(16): report of two cases following paclitaxel-containing chemotherapy and review of the role of intensified ara-C therapy.

Seymour JF, Juneja SK, Campbell LJ, Ellims PH, Estey EH, Prince HM. Seymour JF, et al. Among authors: prince hm. Leukemia. 1999 Nov;13(11):1735-40. doi: 10.1038/sj.leu.2401552. Leukemia. 1999. PMID: 10557046 Review.

3

A phase II study of dexamethasone, ifosfamide, cisplatin and etoposide (DICE) as salvage chemotherapy for patients with relapsed and refractory lymphoma.

Biagi JJ, Herbert KE, Smith C, Abdi E, Leahy M, Falkson C, Wolf M, Januszewicz H, Seymour JF, Richards K, Matthews JP, Dale B, Prince HM. Biagi JJ, et al. Among authors: prince hm. Leuk Lymphoma. 2005 Feb;46(2):197-206. doi: 10.1080/10428190400014884. Leuk Lymphoma. 2005. PMID: 15621802 Clinical Trial.

4

Ante-mortem diagnosis of localized invasive esophageal aspergillosis in a patient with acute myeloid leukemia.

Chionh F, Herbert KE, Seymour JF, Prince HM, Wolf M, Zimet A, Tam C, Kennedy GA. Chionh F, et al. Among authors: prince hm. Leuk Lymphoma. 2005 Apr;46(4):603-5. doi: 10.1080/10428190400025138. Leuk Lymphoma. 2005. PMID: 16019490

5

Cardiovascular toxicity is increased, but manageable, during high-dose chemotherapy and autologous peripheral blood stem cell transplantation for patients aged 60 years and older.

Mileshkin LR, Seymour JF, Wolf MM, Gates P, Januszewicz EH, Joyce P, Prince HM. Mileshkin LR, et al. Among authors: prince hm. Leuk Lymphoma. 2005 Nov;46(11):1575-9. doi: 10.1080/10428190500235884. Leuk Lymphoma. 2005. PMID: 16236612

6

Myeloma, thalidomide and thrombosis.

Hönemann D, Prince HM. Hönemann D, et al. Among authors: prince hm. Leuk Lymphoma. 2006 Nov;47(11):2273-5. doi: 10.1080/10428190600908562. Leuk Lymphoma. 2006. PMID: 17107896 No abstract available.

7

The troublesome toxicity of peripheral neuropathy with thalidomide.

Mileshkin L, Prince HM. Mileshkin L, et al. Among authors: prince hm. Leuk Lymphoma. 2006 Nov;47(11):2276-9. doi: 10.1080/10428190600948303. Leuk Lymphoma. 2006. PMID: 17107897 No abstract available.

8

An analysis of clinical trials assessing the efficacy and safety of single-agent thalidomide in patients with relapsed or refractory multiple myeloma.

Prince HM, Schenkel B, Mileshkin L. Prince HM, et al. Leuk Lymphoma. 2007 Jan;48(1):46-55. doi: 10.1080/10428190601001904. Leuk Lymphoma. 2007. PMID: 17325847

9

The potential of histone deacetylase inhibitors for the treatment of multiple myeloma.

Prince HM, Bishton M, Harrison S. Prince HM, et al. Leuk Lymphoma. 2008 Mar;49(3):385-7. doi: 10.1080/10428190801950058. Leuk Lymphoma. 2008. PMID: 18297514

10

The development of novel immunotherapeutic approaches in multiple myeloma.

Peinert S, Prince HM, Harrison S. Peinert S, et al. Among authors: prince hm. Leuk Lymphoma. 2008 Apr;49(4):652-4. doi: 10.1080/10428190802007742. Leuk Lymphoma. 2008. PMID: 18398729 Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

447 results

Search Page

Filters